Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/10/23 16:00 | 10/5/23 | MLTX | Health | Drug | Pharmaceutical Preparations | Chen Bihua | MA | T | P | 3,524 | 59.90 | 0 | 59 | 1 | 8,494 | I | |||||||||||||||
10/4/23 17:52 | 10/2/23 | MLTX | Health | Drug | Pharmaceutical Preparations | Chen Bihua | MA | T | P.m | 16,800 | 57.30 | 0 | 293 | 4 | 8,435 | I | |||||||||||||||
7/5/23 16:05 | 6/30/23 | MLTX | Health | Drug | Pharmaceutical Preparations | Chen Bihua | MA | T | P | 40,000 | 50.00 | 0 | 800 | 10 | 8,604 | I | |||||||||||||||
6/28/23 18:28 | 6/26/23 | MLTX | Health | Drug | Pharmaceutical Preparations | Chen Bihua | MA | T | P | 20,535 | 45.63 | 0 | 450 | 6 | 7,804 | I | |||||||||||||||
3/22/23 17:07 | 3/20/23 | MLTX | Health | Drug | Pharmaceutical Preparations | Chen Bihua | MA | T | P.m | 16,775 | 20.28 | 0 | 827 | 14 | 6,892 | I | |||||||||||||||
4/7/22 18:26 | 4/5/22 | MLTX | Health | Drug | Pharmaceutical Preparations | Chen Bihua | MA | T | P.d | 28,500 | 10.00 | 0 | 2,850 | New | 2,850 | I | |||||||||||||||
10/22/20 17:10 | 10/22/20 | HLXA | Financ | AcqCo | Blank Checks | Chen Bihua | MA | DOT | CEO,CB | P | 4,300 | 10.00 | 0 | 430 | New | 430 | I | ||||||||||||||
10/22/20 17:08 | 10/22/20 | HLXA | Financ | AcqCo | Blank Checks | Helix Holdings LLC | MA | DT | P | 4,300 | 10.00 | 0 | 430 | New | 430 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |